US COURT DISMISSES PATENT INFRINGEMENT SUIT AGAINST L’ORÉAL
THE WHAT? A District of Columbia federal court has thrown out a case bought by GlycoBioSciences charging L’Oréal with patent infringement, citing a lack of jurisdiction, according to a report published by Law Street Media.
THE DETAILS The Canadian cosmetics and pharmaceutical company claimed that L’Oréal SA infringed its US patents for a specific gel and polymer matrix.
THE WHY? The case was dismissed over a lack of jurisdiction with Judge Beryl Howell ruling that the French beauty giant does not have sufficient contacts within the US as it is distinct from its US subsidiary, which has its own licensing and distribution agreements. The court did not comment on whether the French beauty giant did or did not infringe the patents in question or not.
You May Interested In
2026-10-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Kering and L'Oréal Form $4 Billion Strategic Alliance in Luxury Beauty and Wellness
-
L’Oréal Middle East Partners with BinSina Pharmacy to Promote Sustainable Beauty in the UAE
-
L’Oréal and Tru Diagnostic Collaborate on Epigenomic Research in Beauty and Personal Care
-
L’Oréal Opens New $160 Million R&D Center in New Jersey
-
L’Oréal and IBM Partner to Develop AI Models to Formulate More Sustainable Cosmetics
-
L’Oréal partners with Abolis Biotechnologies and Evonik to advance sustainable biobased beauty goals
-
H1 2024: L’Oréal stellar despite China blemishes
-
L’Oréal acquires 10% stake in Galderma
-
Galderma and L’Oréal enter into a scientific partnership
-
Debut and L’Oréal are developing more than 12 bioidentical, biobased alternatives to traditional cosmetic ingredients
Recommend Reading
-
![Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A]()
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
![AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale]()
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
![Iran Conflict Leaves a Long Shadow on Drug Supply]()
Iran Conflict Leaves a Long Shadow on Drug Supply
-
![McKinsey Pays to Close a Purdue Liability Chapter]()
McKinsey Pays to Close a Purdue Liability Chapter
-
![Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency]()
Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency
-
![Supply and Demand Weakness, Flexible Fluctuations in the Melamine Market]()
Supply and Demand Weakness, Flexible Fluctuations in the Melamine Market
-
![Business Society’s Ethanol Market Outlook on August 25, 2026: Clearly Upward Trend]()
Business Society’s Ethanol Market Outlook on August 25, 2026: Clearly Upward Trend
-
![Cost Advantages Support, Polyester Staple Fiber Prices Remain on an Upward Trend]()
Cost Advantages Support, Polyester Staple Fiber Prices Remain on an Upward Trend
-
![Business Society’s Market Outlook for Ethanol on August 24, 2026: Slightly Bearish Correction]()
Business Society’s Market Outlook for Ethanol on August 24, 2026: Slightly Bearish Correction
-
![Business Society’s Market Outlook for Ammonium Sulfate on August 25, 2026: A Volatile Pattern]()
Business Society’s Market Outlook for Ammonium Sulfate on August 25, 2026: A Volatile Pattern
